{"id":167699,"name":"HEALTHCARE INSTITUTE OF NEW JERSEY","slug":"healthcare-institute-of-new-jersey","state":"NJ","country":"United States of America","description":"","totalSpending":1727658,"filings":33,"yearlySpending":[{"year":2018,"income":198920},{"year":2019,"income":257662},{"year":2020,"income":191751},{"year":2021,"income":232782},{"year":2022,"income":196502},{"year":2023,"income":250811},{"year":2024,"income":214100},{"year":2025,"income":185130}],"issues":["HCR"],"firms":["HEALTHCARE INSTITUTE OF NEW JERSEY"],"lobbyists":["DEAN PARANICAS","STEVE ISSENMAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Disease Control & Prevention (CDC)","Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","White House Office","Federal Trade Commission (FTC)","Environmental Protection Agency (EPA)","Commerce, Dept of (DOC)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Promoting awareness of the biopharmaceutical and medical technology sectors\nOpposing the imposition of price controls in the Medicare program\nGenerally supporting intellectual property rights\nGenerall","Promoting awareness of the biopharmaceutical and medical technology sectors\nOpposing the imposition of price controls in the Medicare program\nGenerally supporting intellectual property rights\nGenerall","Promoting awareness of the biopharmaceutical and medical technology sectors\nOpposing the imposition of price controls in the Medicare program\nGenerally supporting intellectual property rights\nGenerall","Promoting awareness of the biopharmaceutical and medical technology sectors\nOpposing the imposition of price controls in the Medicare program\nGenerally supporting intellectual property rights\nGenerall","Promoting awareness of the biopharmaceutical and medical technology sectors.\nOpposing the imposition of price controls in the Medicare Part D program.\nGenerally supporting intellectual property rights"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}